For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?

Int Psychogeriatr. 2008 Apr;20(2):259-92. doi: 10.1017/S1041610207006680. Epub 2008 Feb 6.
No abstract available

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / epidemiology*
  • Cholinesterase Inhibitors / therapeutic use*
  • Cognition Disorders / diagnosis
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / epidemiology*
  • Donepezil
  • Galantamine / therapeutic use*
  • Humans
  • Indans / therapeutic use*
  • Neuropsychological Tests
  • Piperidines / therapeutic use*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Indans
  • Piperidines
  • Galantamine
  • Donepezil